The Latest Advances in CAR T-Cell Therapy for Refractory and Relapsed Lymphomas and Leukemias

Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.

Axis Logo

Faculty

Marco L. Davila, MD, PhD
Associate Member
Department of Blood and Marrow Transplantation
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida

This activity is supported by an educational grant from Kite Pharma, Inc.

Save

Save

Save

Save

Save

Save

Save


Continuing Education

CAR T-Cell Therapy: An Approach Whose Time Has Come



Read More
Continuing Education

The Latest Advances in CAR T-Cell Therapy for Refractory and Relapsed Lymphomas and Leukemias

Marco L. Davila, MD, PhD

Read More
Copyright © 2010-2023 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.